Document is current
Any future updates will be listed below
-
Authors
Pu, Zhangya http://orcid.org/0000-0002-5721-3512
Duda, Dan G.
Zhu, Yuanyuan
Pei, Siya
Wang, Xiaofang
Huang, Yan
Yi, Panpan
Huang, Zebing
Peng, Fang
Hu, Xingwang
Fan, Xuegong
-
Funding
Funding for this research was provided by:
National Natural Sciences Foundation of China (No.81970523)
National Natural Sciences Foundation of China (81800506)
the National Science and Technology Major Project of China (2017YFC0908104, 2018ZX10732202)
the International Scientific and Technology Cooperation Program of China (2015DFA31490)
Natural Sciences Foundation of Hunan province (2020JJ4877)
and Natural Sciences Foundation of Hunan province (2019JJ40496)
US National Cancer Institute grants (R01CA260872, R01CA260857)
DoD PRCRP Impact Award (W81XWH-19-1-0284)
- License Information
-
More Information
Article History
Received: 5 January 2022
Accepted: 27 April 2022
First Online: 13 May 2022
Declarations
:
: This study was conducted following the standards of the Institute Research Ethics Committee of Xiangya Hospital, Central South University, Changsha, China.
: All authors agree to submit the research article for publication.
: Dr. Duda received consultant fees from Bayer, BMS, Simcere, Sophia Biosciences, and Surface Oncology and has received research grants from Bayer, Merrimack, Exelixis, and BMS. No reagents or support from these companies were used for this study. All the other authors declare that they have no competing interests.
